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Systematic reviewA body of evidence suggests that myocardial infarctions (MI) that are associated with percutaneous coronary
intervention (PCI) have prognostic signiﬁcance but it is uncertain whether remote ischaemic preconditioning
(RIPC) offers periprocedural cardioprotection at the time of PCI.
Medline, Embase, the Cochrane Central Register of Controlled Trials and conference records were searched
(January 1986 to August 2013) for randomised trials that evaluated the effect of RIPC induced by limb
ischaemia–reperfusion versus no RIPC in patients who were undergoing PCI. All outcomes were considered for
inclusion in the systematic review. Relevant data were extracted and summarised. Pooled odds ratios determined
the effect of RIPC compared to control on three prespeciﬁed outcomes: troponin positive events in elective PCI,
periprocedural MI incidence in elective PCI and acute kidney injury (AKI) incidence in emergency or elective PCI.
Eight trials (1119 patients) were found ofwhich six (983 patients) had primary outcomes that were signiﬁcantly
in favour of RIPC. There was no difference in troponin positive events between RIPC and control groups (pooled
OR 0.529, 95%CI 0.206–1.358, p = 0.185) (three studies, 377 patients). There was a signiﬁcant reduction in
periprocedural MI incidence with RIPC (pooled OR = 0.577, 95%CI 0.400–0.833, p = 0.003) (four studies, 636
patients). There was no difference in AKI incidence (pooled OR = 0.672, 95%CI 0.252–1.787, p = 0.425)
(two studies, 407 patients).
Primary outcomes favoured RIPC in most of the studies. RIPC signiﬁcantly reduced the incidence of
periprocedural MI. Included studies were heterogeneous in methodology and quality.
© 2013 The Authors. Published by Elsevier Ireland Ltd. Open access under CC BY-NC-ND license.Introduction
Percutaneous coronary intervention (PCI) is a key component of the
management of coronary artery disease [1]. About 1.5 million people
undergo PCI in the United States each year and about 5 to 30% of these
patients develop periprocedural myocardial infarction (MI), depending
on the deﬁnitions used [2]. Though there is controversy regarding the
prognostic signiﬁcance of most small periprocedural MIs, a body ofliability and freedom from bias
raduate Entry Medical School,
land Ltd. Open access under CC BY-NCevidence suggests that periprocedural MIs are associated with adverse
outcomes [2]. Therefore, there is a need for a simple and cheap interven-
tion that might offer periprocedural cardioprotection. Remote ischae-
mic preconditioning (RIPC) may be suitable for this role.
Ischaemic preconditioning (IPC) is a phenomenon whereby brief
periods of ischaemia in an organ or tissue can confer resistance against
subsequent more sustained ischaemic insults [3]. In trials on cardiac
surgery, IPC has been shown to reduce arrhythmia rates, inotrope
requirements and intensive care unit length of stay [4] but the need
for direct interference with coronary blood ﬂow limits its utility. Subse-
quently, it was shown that episodic ischaemia in distant organs or
tissues can induce cardioprotection [5,6] — this concept was termed
RIPC. Multiple exploratory studies have evaluated the role of RIPC in a
wide range of cardiovascular interventions (including four PCI trials)
and meta-analysis has shown reductions in biomarkers of myocardial
injury with RIPC [7]. However, to date there has been no systematic re-
view that examined the effect of RIPC in PCI solely. Performing such a
PCI review is worthwhile as vascular surgery, cardiac surgery and PCI
have different risk proﬁles — conclusions derived from pooled data
may not apply to the individual subgroups. Therefore we performed a
systematic review and meta-analysis of RIPC in PCI.-ND license.
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This systematic reviewwasperformed in accordancewith the PRISMA
guidelines [8] and it followed a pre-speciﬁed but unpublished protocol.
Medline, EMBASE and the Cochrane Central Register of Controlled
Trials were searched from 1986 to 12th August 2013 using the search
(ischaemic preconditioning OR ischemic preconditioning OR remote
preconditioning OR remote ischaemic preconditioning OR remote is-
chemic preconditioning). Conference proceedings from the American
College of Cardiologists (2002–2013), American Heart Association
(2002–2012), British Society of Cardiologists (2002–2013) and
European Society of Cardiologists (2002–2012) were searchedmanual-
ly. Eligible studies provided any clinical or biochemical outcomes from
randomised controlled trials that compared RIPC induced by transient
limb ischaemia with no RIPC in patients who were undergoing emer-
gency or elective PCI. There was no language restriction and there
were no exclusion criteria.
Two authors (DH and PC) screened titles and abstracts for eligibility.
Manuscripts of potentially relevant articles were retrieved and exam-
ined (DH and PC) to ﬁnalise eligibility. Uncertainties were resolved by
discussion with another author (SRW). The citation lists of included
articles were examined for further relevant publications (DH and PC).
For each included study, the following data were extracted (DH and
PC): publication year, recruitment period, whether the study involved
emergency or elective PCI, details on trial participants, exclusion
criteria, details on the nature of the RIPC stimulus, outcomes included
and results. An attempt was made to contact authors via email if study
manuscripts did not provide details on the numbers of patients who
had troponin positive events, periproceduralMIs and acute kidney inju-
ry (AKI). Data were entered into a computerised spreadsheet for analy-
sis. Outcomes considered for meta-analysis were incidence of troponin
positive events within 24 h of elective PCI, incidence of periprocedural
MI following elective PCI and incidence of AKI in elective or emergency
PCI. The deﬁnitions for outcomes were the deﬁnitions speciﬁed in the
manuscripts of included studies. Study quality was assessed by one au-
thor (DH) by applying the Cochrane Collaboration's tool for assessingPotentially relevant articles n=7331
(n=7012 Embase and Medline, n=319 C
M
D
C
R
D
Full manuscripts screened
(n = 23)
Articles eligible for inclusion
(n=8)
Fig. 1. Summary of thrisk of bias [9] to each study and by reviewing protocols if they were
available.
Statistical analyses were performed using Statsdirect 2.5.7
(Statsdirect Ltd., Altrincham, UK). Pooled odds ratios (OR) were used to
calculate the effect of RIPC on troponin positive events, periprocedural
MI and AKI. These were determined using random effects modelling as
described by DerSimonian et al. [10]. Statistical heterogeneity was
assessed by Cochran's Q statistic, a hypothesis test in which a p value
below 0.05 is taken to indicate the presence of signiﬁcant heterogeneity.
Results
The literature search identiﬁed 7331 sources. Fig. 1 summarises the
result of the search. In total, 7308 citationswere excluded based on titles
and abstracts. 23 full text articles were screened. When ineligible stud-
ies were excluded, 8 fulﬁlled the criteria for inclusion in the systematic
review. No additional studies were found from the grey literature or
from included article reference lists.
The eight [11–18] included studies (1119 patients) are summarised
in Table 1. Six studies involved elective PCI [11–13,15–17] (772 pa-
tients) and two studies [14,18] (347 patients) involved emergency PCI
for ST elevation MI (STEMI). All studies were parallel group trials —
seven trials had 1:1 allocation ratios and one study [14] involved a
1:1:1 ratio: RIPC, RIPC with morphine and control groups. For the pur-
poses of this review, RIPC and RIPC with morphine were combined
and comparedwith the control arm. Six of the studies used cuff induced
ischaemia–reperfusion of one upper limb to induce the RIPC stimulus
[11,13,14,16–18], one study applied the stimulus to both upper limbs
[15] and one study used the lower limb for the stimulus [12]. The dura-
tion of ischaemia reperfusion cycles also varied between studies. Six
studies [11–13,15–17] used cardiac enzyme levels as primary outcomes,
one trial [14] used the number of patientswith ST segment resolution as
the primary outcome and one trial [18] used myocardial salvage index
as the primary outcome. Overall, six trials had primary outcome results
that signiﬁcantly favoured RIPC [11–14,17,18], one trial found no differ-
ence between RIPC and control [16] and one trial found a signiﬁcantochrane)
anuscripts excluded (n=15):
irect preconditioning (n=2)
oronary angiography only (n = 1)
eviews, editorials, letters (n=8) 
uplication of included data (n=4)
Not relevant after title and abstract review 
and removal of duplicates
(n = 7308)
e search results.
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ity assessment.
Table 3 summarises the available data on the three prespeciﬁed
outcomes for meta-analysis. Three studies (377 patients) [12,16,17]
provided data on the incidence of troponin positive events. Troponin
positive events occurred in 87/191 RIPC patients and in 109/186 con-
trols. There was evidence of heterogeneity between studies (Cochran
Q = 7.79, p = 0.02). The random effects model demonstrated no
signiﬁcant difference in troponin positive events between groups
(pooled OR = 0.529, 95%CI 0.206–1.358, p = 0.185).
Four studies (636patients) [11–13,17] provideddata onperiprocedural
MI. Periprocedural MI occurred in 92/322 RIPC patients and in 122/314
controls. There was no evidence of heterogeneity between studies
(Cochran Q = 0.95, p = 0.62). The random effects model demonstrat-
ed a signiﬁcant reduction in periprocedural MI with RIPC (pooled
OR = 0.577, 95%CI 0.400–0.833, p = 0.003) (Fig. 2).
Two studies (407 patients) [13,17] provided data on AKI. AKI
occurred in 8/205 RIPC patients and in 11/202 controls. There was no
evidence of heterogeneity between studies (Cochran Q = 1.01,
p = 0.31). The random effects model demonstrated no signiﬁcant dif-
ference in AKI (pooled OR = 0.672, 95%CI 0.252–1.787, p = 0.425).
Discussion
This systematic review identiﬁed eight studies [11–18] (1119 pa-
tients) that examined the cardioprotective potential of RIPC in PCI. Six
of these studies [11–14,17,18] (983 patients) had primary outcomes
that signiﬁcantly favoured RIPC. We performedmeta-analysis of pooled
data relating to three pre-speciﬁed outcomes: number of troponin
positive events following elective PCI (377 patients) [12,16,17],
periprocedural myocardial infarction incidence in elective PCI (636 pa-
tients) [11–13,17] and acute kidney injury incidence in elective or
emergency PCI (407patients) [13,17]. No differencewas found between
RIPC and control groups in relation to the incidence of troponin positive
events or AKI— this is unsurprising given that these datawere not avail-
able for many of the included studies despite an effort to contact indi-
vidual study authors. However, our results show a signiﬁcant beneﬁt
with RIPC in terms of reduction in the incidence of periprocedural MI
(OR = 0.577, 95%CI 0.400–0.833, p = 0.003). Although we were un-
successful in attempts to acquire unpublished data on MI rates in two
elective PCI studies [15,16], themissing data relate to a small proportion
(137/772) of elective PCI patients. Overall, this systematic review pro-
vides an up-to-date summary of the current status of RIPC in PCI and
it represents a valuable opportunity to critically review prior studies
and to consider future goals. In relation to themeta-analysis, theﬁnding
of reduced periproceduralMI incidencewith RIPC highlights the impor-
tance of performing meta-analysis — though meta-analysis is not a
ﬂawless technique, the result compliments the proof of concept studies
and may focus future research on RIPC.
Conclusions from a systematic review can only be as strong as the in-
dividual studies — in this review the included studies were heteroge-
neous in methodology (Table 1) and in quality (Table 2). Studies
included patients with varying demographics undergoing both emer-
gency and elective PCI with varying RIPC stimuli. Furthermore a range
of primary outcome measures were used that included biochemical,
electrocardiographic and radiographic endpoints. The method of
reporting cardiac biomarker endpoints also differed between studies
— some studies used biomarker positive events and others used mean
and median biomarker levels. The hazards of this approach and the im-
portance of having a published trial protocol with predeﬁned outcomes
are illustrated in the results of the Ghaemian et al trial [12]—mean tro-
ponin T was signiﬁcantly higher at 24 h in the RIPC group compared to
control (0.063 ng/ml versus 0.016 ng/ml, p = 0.009) but the number of
troponin positive events at 24 h was signiﬁcantly lower in the RIPC
group compared to control (5/40 versus 16/40, p = 0.01). Among the
included studies, secondary outcomes were also diverse althoughsome overlap existed. Despite the large amount of clinical heterogene-
ity, the ﬁnding that six of the eight studies were in favour of RIPC repre-
sents a promising result. If one adopts an optimistic viewpoint, it
could be argued that the study by Iliodromitis et al. [15] (it found a sig-
niﬁcantly worse result with RIPC) was limited by a small sample size
and that the Prasad et al study [16] (it found no difference between
RIPC and control) may have experienced a type two error. A more con-
servative viewpoint would be to consider individual study weaknesses
and biases (Table 2) and await large studies that address these problems
before drawing conclusions. Regarding the meta-analyses, we reiterate
that we extracted data based on deﬁnitions speciﬁed in the relevant
manuscripts (Table 3) and that these deﬁnitions differed between
studies, most notably for periprocedural MI.
The strengths of this review relate to the thorough search strategy
(including a detailed grey literature search), the predeﬁned outcomes
for meta-analysis and the large number of included patients. Further-
more, the application of the Cochrane bias assessment tool has added
transparency and highlights areas that researchers could consider ad-
dressing. The principle limitation of this review is that heterogeneity
of the included studies may limit extrapolation. However, highlighting
this may help to guide future studies. Furthermore, the reported results
represent published data only as we were unsuccessful in attempts to
acquire unpublished data. As a result, the pooled outcomes described
in this article correspond to a subset of the total number of relevant
patients. As mentioned, the principle limitation of the meta-analyses,
particularly the MI analysis, is that deﬁnitions differed between studies.
Many studies have conﬁrmed that RIPC attenuatesmyocardial injury
in a variety of cardiovascular interventions [7] and this review strongly
suggests that a cardioprotective role also exists in PCI speciﬁcally. Fur-
thermore, the potential for a long term beneﬁt with RIPC has been sug-
gested by long term follow up of the Hoole et al study [21]. In order for
the beneﬁts of RIPC to be realised, we advocate a shift from surrogate
outcomes and single centre studies to large scale studies with a focus
on patient important outcomes — RIPC's proof of concept foundation
is convincing. If large individual studies can conﬁrm a reduction in
periprocedural MI rates, RIPC use should become widespread before
PCI.
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Table 1
Included study characteristics.
Lead author and
recruitment dates
Nature of PCI
Number of
participants
RIPC: Control
Patients Exclusion criteria Nature of intervention Outcomes reported Results Primary outcome
result favours
RIPC or control
Ahmed 2013 [11]
March to November
2010
Elective PCI
77:72
149 consecutive patients with
undetectable preprocedural cTnT
undergoing elective PCI. Mean
age was 53.5 in controls, and
54.59 in RIPC group. 88 had DES
inserted.
Elevated cTnT at baseline, renal
dysfunction, arteriovenous
ﬁstula, lymphoedema, severe
endocrine or hepatic disease.
3 × 5 min cycles of cuff
induced upper limb
ischaemia with 5 min
reperfusion between
cycles, immediately before
arrival in catherisation
room.
Primary outcome: cTnT at 16 h.
Secondary outcomes: MI rates,
CKMB levels at 16 h, CRP level at
16 h.
Mean cTnT was 0.020 ng/ml in RIPC
group versus 0.047 ng/ml in controls
(p = 0.047). Secondary outcomes
were not different.
RIPC was
signiﬁcantly
better
Ghaemian 2012 [12]
2008 to 2009
Elective PCI
40:40
80 consecutive patients
undergoing elective PCI with DES
insertion. Mean age in controls
was 61, mean age in RIPC group
was 58.8. A mildly elevated cTnT
was not an exclusion.
Emergency PCI, angina in 48 h
before procedure, previous MI
within 6 weeks, nicorandil or
suplhonylurea, PVD.
2 × 5 min cycles of cuff
induced lower limb
ischaemia with 5 min
reperfusion between
cycles, one hour before the
procedure.
Primary outcomes: Number of
patientswith elevated cTnT at 24 h.
Secondary outcomes: arrythmias,
postprocedural chest pain, ST seg-
ment deviation, death within
28 days, MI rates, emergency
revascularisation rates, long term
MACE (hospitalisation for ACS, MI
or death due to MI).
Numbers of patients with cTnT
elevations at 24 h were higher in
control group (16/40 control, 5/40
RIPC, p = 0.01). However, mean cTnT
at 24 h was 0.063 ng/ml in RIPC ver-
sus 0.016 in controls (p = 0.009).
RIPC reduced ST segment deviation
time (p = 0.02). No other secondary
outcome difference.
RIPC was
signiﬁcantly
better
Luo 2012 [13]
March to August
2012
Elective PCI
101:104
205 patients undergoing elective
PCI with DES insertion. Mean age
in controls was 59.3, mean age in
RIPC group was 59.2.
Emergency PCI, baseline
cTnI N 0.04 ng/ml, nicorandil or
glibenclamide medication,
second PCI of a staged procedure.
3x5 min cycles of cuff
induced upper limb
ischaemia with 5 min
reperfusion between
cycles, less than 2 h before
PCI procedure.
Primary outcome: hsTnI at 16 h, MI
at 16 h. Secondary outcomes: cre-
atinine, eGFR and AKI at 16 h.
Median hsTnI was 0.11 ng/ml in RIPC
group versus 0.21 ng/ml in controls
(p b 0.01). MI rates were lower with
RIPC also (39/101with RIPC versus 57/
104 with control, p = 0.029). Sec-
ondary outcomes not different.
RIPC was
signiﬁcantly
better
Rentoukas 2010 [14]
Recruitment period
was not speciﬁed
Emergency PCI
66:30
96 patients undergoing
emergency PCI for STEMI. There
were three arms: RIPC, RIPC with
morphine, control. Mean age in
controls was 61.2 (n = 30).
Mean age across the two RIPC
groups was 63.4 (n = 66).
Shock, moderate/severe renal
impairment
(creatinine N 1.5 mg/dl).
3 × 4 min cycles of cuff
induced upper limb
ischaemia with 4 min
reperfusion between
cycles, starting 10 min
before estimated time for
ﬁrst balloon inﬂation.
Primary outcome: number of
patients with ST segment resolu-
tion 30 min after PCI. Secondary
outcomes: percentage reduction in
ST segment deviation score be-
tween presentation and 2 h post
procedure, peak cTnI during
hospitalisation.
More people who had RIPC had full ST
segment resolution (51/66 compared
with 16/30; p = 0.03a). Signiﬁcant
improvements in ST segment resolu-
tion score with RIPC. Peak cTnI levels
with RIPC were 134.7 ng/ml SEM15.9
versus control 255.5 ng/ml SEM 35.5,
p = 0.003.
RIPC was
signiﬁcantly
better
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Iliodromitis 2006 [15]
Not speciﬁed
Elective PCI
20:21
41 consecutive patients
undergoing elective PCI. Mean
age in controls was 62 and mean
age in RIPC group was 61.
ACS, complex lesions, additional
cardiac disease, renal/hepatic
disease, malignancy, rheumatoid
arthritis, active infection.
3 × 5 min cycles of cuff
induced ischaemia of both
upper limbs, with 5 min
reperfusion between
cycles. Angioplasty was
carried out immediately
after.
The primary outcome was not
speciﬁed. Outcomes were CK,
CKMB, cTnI, CRP at 12,24,48 h.
AUC for CKMB was signiﬁcantly
greater in RIPC group (83 SEM 24
versus 21 SEM 8; p b 0.05).
AUC for TnI was also greater in RIPC
group (24 SEM 7 versus 8 SEM 1.7;
p b 0.05). No difference in CRP or CK
between groups.
Control was
signiﬁcantly
better
Prasad 2013 [16]
November 2006 to
November 2008
Elective PCI
47:48
95 patients undergoing non-
emergency PCI for stable or un-
stable angina. Mean age in con-
trols was 65.1, mean age in RIPC
group was 67.2.
Preprocedural cTnT ≥ 0.03 ng/dl,
emergency PCI, hypotension
(b90 mmHg systolic), shock,
arteriovenous ﬁstula or
lymphoedema, pregnancy or
lactation, severe comorbidity.
3 × 3 min cycles of cuff
induced upper limb
ischaemia with 3 min
reperfusion between
cycles immediately
preceding PCI
Primary outcome: Number of
patients with peak cTnT
≥0.003 ng/dl, checked at 6, 12,
24 h. Secondary outcomes: CKMB
(at 6, 16, and 24 h) and CRP levels
(16 h) and endothelial progenitor
cell counts.
No difference in primary or secondary
outcomes with the exception of CKMB
levels which were higher in RIPC
group at 24 h only.
No difference was
found
Hoole 2009 [17]
July 2006 to
November 2009
Elective PCI
104:98
202 consecutive patients with
undetectable preprocedural cTnI
undergoing elective PCI and stent
insertion. Mean age in controls
was 61.8 and in the RIPC group it
was 63.2.
Emergency PCI, women of child
bearing age, nicorandlil or
glibenclamide use, life
expectancy b 6 months.
3x5 min cycles of cuff
induced upper limb
ischaemia with 5 min
reperfusion between
cycles, starting about an
hour before the procedure.
Primary outcome: cTnI at 24 h.
Secondary outcomes: ischaemic
symptoms, ECG evidence of is-
chaemia during balloon inﬂation,
renal dysfunction, adverse cardiac
and cerebral events at 6 months.
Median cTnI at 24 h was 0.06 ng/ml
IQR 0.02–0.56) in RIPC group versus
0.16 ng/ml IQR (0.04–1.04) in con-
trols, (p = 0.04). There was less chest
discomfort (p = 0.0006) and ST seg-
ment deviation (p = 0.005)with RIPC
also. Major adverse cardiac and cere-
bral events at 6 months were lower
with RIPC (4 versus 13, p = 0.018).
RIPC was
signiﬁcantly
better
Botker 2010 [18]
February 2007 to
November 2008
Emergency PCI
for STEMI
126:125
However, 73:69
had primary
outcome assess-
ment at 30 days.
251 patients undergoing
emergency PCI for STEMI. Mean
age in controls was 63 and mean
age in RIPC was 62.
Left bundle branch block,
previous MI, ﬁbrinolytic therapy
within 30 days, previous CABG,
left main stem disease requiring
CABG, severe heart failure re-
quiring mechanical ventilation or
a balloon pump.
4x5 min cycles of cuff
induced upper limb
ischaemia with 5 min
reperfusion between
cycles, starting during
transit to the hospital.
Primary outcome: myocardial
salvage index at 30 days.
Secondary outcomes: ﬁnal infarct
size at 30 days, cTnT levels,
markers of reperfusion, death,
reinfarction, admission with heart
failure within 30 days, LVEF, NYHA
class at 30 days.
Higher median salvage index with
RIPC in the per protocol analysis—RIPC
(n = 73) 0.75 IQR 0.5–0.93 versus
control (n = 69) 0.55 IQR-0.35–0.88.
Median difference 0.10 95%CI 0.01–
0.22, p = 0.033.) No difference in
other outcomes.
RIPC was
signiﬁcantly
better
ACS— acute coronary syndrome; AUC— area under the curve; CABG— coronary artery bypass graft; CK— creatine kinase; CKMB— creatine kinaseMB isoenzyme; CRP— C reactive protein; cTnI— cardiac troponin I; cTnT— cardiac troponin T; DES—
drug eluting stent; ECG— electrocardiograph; eGFR— estimated glomerular ﬁltration rate; IQR— interquartile range; LVEF— left ventricular ejection fraction; MI—myocardial infarction; NYHA — New York Heart Association; PCI— percutaneous
coronary intervention; RIPC — remote ischaemic preconditioning; SEM — standard error of the mean.
a This hypothesis test was performed by using Fisher's exact test on data extracted from the Rentoukas et al manuscript.
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Table 2
Results of the study quality assessment.
Included study Domain Support for judgement DH's judgement
Ahmed 2013
[11]
Random sequence generation No description of random sequence generation. Unclear
Allocation concealment No description of methods for maintaining allocation concealment Unclear
Blinding of participants and personnel No sham procedure. No mention of blinding patients and personnel. High risk of bias
Blinding of outcome assessment No mention of blinding of assessors. High risk of bias
Incomplete outcome data Number of excluded patients and attrition rates were not speciﬁed. Amount of missing data was not
speciﬁed.
Unclear
Selective reporting No link to trial protocol was given. All outcomes speciﬁed in manuscript were reported. Unclear
Other sources of bias None Not available
Ghaemian 2012
[12]
Random sequence generation Computer randomisation was speciﬁed. Low risk of bias
Allocation concealment No description of methods for maintaining allocation concealment. Unclear
Blinding of participants and personnel Controls had placement of a non inﬂated cuff. An independent team member applied RIPC and
ﬁnished 45 min before procedures began.
High risk of bias
Blinding of outcome assessment No mention of blinding of assessors. Unclear
Incomplete outcome data Attritions and exclusions are described. No mention of amount of missing data. Unclear
Selective reporting The protocol says that cTnT levels are the primary outcome. It does not specify how levels are
interpreted. The manuscript dichotomises these results into N0.03 ng/ml and b0.03 ng/ml. RIPC is
favoured using the dichotomy but not when results are analysed continuously using mean values.
Unclear
Other sources of bias None Not available
Luo 2013 [13] Random sequence generation The method of generating the random sequence was not described. Unclear
Allocation concealment No description of methods for maintaining allocation concealment. Unclear
Blinding of participants and personnel No sham procedure was employed. RIPC started 2 h before PCI. High risk of bias
Blinding of outcome assessment Outcomes were biochemical and assessors did not know allocation. Low risk of bias
Incomplete outcome data Attrition rates and exclusions are not described. No mention of amount of missing data. Unclear
Selective reporting No link to trial protocol was given. All outcomes speciﬁed in manuscript were reported Unclear
Other sources of bias None Not available
Rentoukas 2009
[14]
Random sequence generation The method of generating the random sequence was not described. Unclear
Allocation concealment No description of methods for maintaining allocation concealment. Unclear
Blinding of participants and personnel Controls had inﬂation of an arm cuff to 20 mmHg. High risk of bias
Blinding of outcome assessment Physicians assessing the primary outcome were blinded with no mention of blinding of other assessors Low risk of bias
Incomplete outcome data Number of excluded patients and attrition rates were not speciﬁed. Amount of missing data was not
speciﬁed.
Unclear
Selective reporting No link to trial protocolwas given. All outcomes speciﬁed inmanuscriptwere reported.Mortalitywas
not reported but is relevant in a primary PCI study.
Unclear
Other sources of bias None Not available
Iliodromitis
2006 [15]
Random sequence generation The method of generating the random sequence was not described. Unclear
Allocation concealment No description of methods for maintaining allocation concealment. Unclear
Blinding of participants and personnel Controls had placement of non inﬂated cuffs. No blinding of personnel. High risk of bias
Blinding of outcome assessment Blinding of outcome assessors was not mentioned. High risk of bias
Incomplete outcome data Number of excluded patients and attrition rates were not speciﬁed. Amount of missing data was not
speciﬁed.
Unclear
Selective reporting No link to trial protocol was given. All outcomes speciﬁed in manuscript were reported. MI rates are
not reported.
Unclear
Other sources of bias None Not available
Prasad 2013 [16] Random sequence generation The method of generating the random sequence was not described. Unclear
Allocation concealment No description of methods for maintaining allocation concealment. Unclear
Blinding of participants and personnel Controls had inﬂation of a sham cuff to 10 mmHg. No mention of blinding of personnel. High risk of bias
Blinding of outcome assessment Blinding of outcome assessors was not mentioned High risk of bias
Incomplete outcome data Number of excluded patients and attrition rates were not speciﬁed. Amount of missing data was not
speciﬁed.
Unclear
Selective reporting Protocol speciﬁes that primary outcome measurement takes place at 16 h but peak levels were
reported in the manuscript. Protocol mentions non reported secondary outcomes—coronary
perfusionmeasurement and procedural ST segment elevation. These omissions are unlikely to change
conclusions. MI rates were not reported.
Low risk of bias.
Other sources of bias None Not available
Hoole 2009 [17] Random sequence generation A computer generated sequence was used. Low risk of bias.
Allocation concealment Allocationwas concealed using sealed envelopes that were stored in a separate unit and opened only
by independent research staff.
Low risk of bias
Blinding of participants and personnel Controls had placement of a non inﬂated cuff. Interventions were completed before procedures.
Cardiologists did not know allocation.
Low risk of bias
Blinding of outcome assessment Biochemical measurements were made without knowledge of groups. Low risk of bias
Incomplete outcome data There were 21 post randomisation exclusions in the RIPC group and 19 in the control group. Reasons
were similar. It is unlikely that ﬁnal result would be impacted. Only 1 patient was lost to 6 month
follow up.
Low risk of bias.
Selective reporting No detailed protocol was available.
Other sources of bias None Not available
Botker 2010 [18] Random sequence generation A computer generated random sequence was used. Low risk of bias.
Allocation concealment Hospital on call doctors opened sequential sealed opaque envelopes and communicated result to
paramedic team.
Low risk of bias.
Blinding of participants and personnel No sham procedure. Paramedics and cardiologists were not blinded. High risk of bias.
Blinding of outcome assessment Data analysts were blinded. Low risk of bias
Incomplete outcome data Exclusions and attritions are documented. 82 patients were excluded post randomisation. RIPC and
control exclusions were similar and unlikely to introduce selection bias.
Low risk of bias.
Selective reporting The protocol mentions some secondary outcomes that are not reported in the manuscript. Low risk of bias
Other sources of bias None Not available
cTnT— cardiac troponin T; MI—myocardial infarction; PCI — percutaneous coronary intervention; RIPC— remote ischaemic preconditioning.
18 D.A. Healy et al. / IJC Metabolic & Endocrine 1 (2013) 13–19
Table 3
Summary of the data used in the meta-analysis.
Troponin positive events
Study Deﬁnition used for troponin positive
events
RIPC participant number Number of troponin
positive events in RIPC
group
Control participant
number
Number of troponin positive
events in control group
Ghaemian cTnT N 0.03 ng/ml at 24 h 40 5a 40 16a
Prasad cTnT ≥ 0.03 ng/dl at 24 h 47 22 48 19
Hoole cTnI ≥ 0.04 ng/ml at 24 h 104 60 98 74
Myocardial infarction
Study Deﬁnition used for MI RIPC participant number Number of MIs in RIPC
group
Control participant
number
Number of MIs in control
group
Ahmed 2007 type 4a MI deﬁnition [19], speciﬁed
as cTnT increase of greater than 3 times
the 99th percentile URL
77 6 72 12
Ghaemian no deﬁnition was speciﬁed 40 0 40 0
Luo 2012 type 4a MI deﬁnition [20], speciﬁed
as HscTnI increase of greater than 5 times
99th percentile URL corresponding to
HscTnI N 0.2 ng/ml
101 39 104 57
Hoole 2007 type 4a MI deﬁnition [19], speciﬁed
as cTnI increase of greater than 3 times the
99th percentile URL corresponding to
cTnI N 0.12 ng/ml
104 47 98 53
Acute kidney injury
Study Deﬁnition used for AKI RIPC participant number Incidence o f AKI in RIPC
group
Control participant
number
Incidence of AKI in control
group
Luo N25% increase in serum creatinine from
baseline level, checked at 16 h
101 2 104 1
Hoole N25% increase in serum creatinine from
baseline level, checked at 24 h
104 6 98 10
AKI — acute kidney injury; cTnI — cardiac troponin I; cTnT — cardiac troponin T; HscTnI — highly sensitive cardiac troponin I; MI — myocardial infarction; RIPC — remote ischaemic
preconditioning; URL — upper reference limit.
a At baseline, 2/24 inRIPC group and6/24 in control groupwere troponin positive— thesepatients are included in thepost procedure troponin positive group. This study did not exclude
participants on the basis of preprocedural troponin levels.
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